Trial Profile
Patterns of ipilimumab (IPI) usage and health care resource utilization in a retrospective analysis of patients (pts) with melanoma covered in a large U.S. claims database
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 21 Jul 2015
Price :
$35
*
At a glance
- Drugs Ipilimumab (Primary)
- Indications Malignant melanoma
- Focus Therapeutic Use
- 21 Jul 2015 New trial record
- 02 Jun 2015 Results presented at the 51st Annual Meeting of the American Society of Clinical Oncology.